1. ABERRANT HYPEREDITING OF MYELOMA TRANSCRIPTOME BY ADAR1 CONFERS ONCOGENICITY AND IS A MARKER OF POOR PROGNOSIS. (12th June 2019) Authors: Teoh, P.; An, O.; Chung, T.; Chooi, J.; Toh, S.; Fan, S.; Wang, W.; Koh, B.; Fullwood, M.; Ooi, M.; de Mel, S.; Soekojo, C.; Chen, P.; Ng, S.; Yang, H.; Chng, W. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 549 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗